Published: March 08, 2010
10 Small Businesses Awarded Scholarships to Attend International Biotechnology Convention, Other Funds Still Available
MADISON, Wis. - (BUSINESS WIRE) - Ten Wisconsin biotechnology companies have been awarded scholarships of
$1,100 each to support them in attending the Biotechnology Industry
Organization's (BIO) International Convention at Chicago's McCormick
Place May 3-6, 2010 in Chicago. All recipients plan to participate in
BIO's one-on-one partnering with potential customers from around the
world, or to present to potential investors.
The grant fund was assembled by BioForward, and includes funds provided
by BioForward, Alliant Energy, the City of Madison, Thrive, and the
University of Wisconsin-Madison Center for International Business
Education and Research (CIBER). Scholarship recipients are small
biotechnology businesses that demonstrate a strategic approach to the
Business Forum, and have a financial need.
Companies still seeking support to attend the International
Biotechnology Convention are encouraged to apply to the Wisconsin
Department of Commerce Trade Show Grant Program. Visit http://www.commerce.state.wi.us/ie/ie-tradeshowgrant.html
to download application materials or contact Christine Stamm at christine.stamm@wisconsin.gov
or (608) 264-7824.
The scholarship recipients are:
Addiction Therapeutix Inc. (Wauwatosa) -- Develops proprietary
compounds for the treatment of various addictions and related illnesses.
The company is currently focused on the development of medications for
Co-Morbid Alcoholism and Anxiety and Opioid and Nicotine Addiction.
C-56 Technologies (Middleton) -- Develops and commercializes
solutions for the conversion of agricultural and forestry feedstocks
into five carbon and six carbon sugars, high value chemicals, food
products and fuels.
CellCura (Madison) -- Dedicated to the development of novel
equipment and products for use in Assisted Reproductive Technologies and
Stem Cell Research. Products from CellCura will improve safety and
efficiency in both clinical and research environments.
Echometrix (Madison) -- Early-stage developer of proprietary
ultrasound technology that offers a new, quantitative approach to the
assessment of tendon, ligament and muscle pathology.
InvivoSciences (McFarland / Wauwatosa) -- Researches and develops
engineered, tissue-based assays that mimic human and animal functions.
The high-throughput system and ready-to-use tissues grown in a
three-dimensional (3D) environment are predictive and cost-effective.
Intense Engineering (Madison) -- Helps dynamic companies in the
medical and biotechnology fields by providing expert design and
engineering services for technology development and product line
advancement.
Neoclone (Madison) -- Develops monoclonal antibodies for research
and diagnostic applications and has a research program for making human
therapeutics.
Primorigen (Madison) -- Develops innovative, low cost protein and
cell biology research products to speed development of new regenerative
medicines and other therapeutics for conditions such as diabetes.
Quintessence Biosciences (Madison) - A private biopharmaceutical
company developing anticancer compounds that attack a new target, the
RNA in cancer cells. The company has a drug called QBI-139 in a Phase I
clinical trial.
Vatrix Medical (Fitchburg) -- Medical technology company focused
on developing less invasive and more complete methods to diagnose and
treat the root causes of aneurysmal disease.
"It's critical for these companies to connect with potential customers
and partners from around the world," said Bryan Renk, executive director
of BioForward. "In a tough funding environment we are pleased to be able
to assemble this consortium of partners to fund these promising
Wisconsin companies."
"As a privately-funded company, we have a limited amount of available
capital and are very cautious about expenditures," said Frank Langley,
president and CEO of Addiction Therapeutix. "The BIO 2010 Small Business
Scholarship Award was critical in our decision to attend the Bio 2010
meeting and participate in the various meetings and partnering program."
ABOUT THE SPONSORS
BioForward -- BioForward is the member-driven state association
that is the voice of Wisconsin's biotechnology industry. We advocate
actively on our members' behalf to create investment and partnership
opportunities, attract and retain the very best people, and support
public policy that fosters their continued growth. www.bioforward.org.
Alliant Energy -- Alliant Energy, headquartered in Madison, is an
investor-owned utility providing electric and natural gas service to 1.4
million customers in Wisconsin, Iowa and Minnesota. Biotechnology is one
of our targeted industries and we proudly support the state and regional
efforts to grow this important industry in Wisconsin. www.alliantenergy.com
City of Madison
The City's Economic Development Division is the official liaison between
the business community and the City of Madison. The City, through the
Division's Office of Business Resources (OBR) strives to help advance
Madison's critical mass of both the biotechnology and bioag industry
sectors at the 2010 BIO Conference. http://www.cityofmadison.com/business/OBR/bio.cfm
www.bioaggateway.com
Thrive -- Thrive is the economic development enterprise for the
eight-county Madison Region, created to grow the region's economy in
ways that preserve and enhance the quality of life. www.thrivehere.org
University of Wisconsin-Madison Center for International Business
Education and Research (CIBER) -- Through strategic partnerships
across campus and the state, the University of Wisconsin-Madison CIBER
supports the ability of Wisconsin businesses to compete in the global
marketplace. www.bus.wisc.edu/ciber/
BioForward
Bryan Renk or Karen Dettinger at 608-236-4693
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
